This disclosure relates to a disposable electronically controlled infusion pump system which includes a micropump and is configured for large volume drug delivery. This system is designed to be used only once for a particular patient, and then disposed of. The disposable electronically controlled infusion pump system is configured to be wirelessly controlled by a non-disposable microcontroller which has a micropump in electronic communication with an interface. The non-disposable microcontroller and the interface are configured to be reused to control additional disposable electronically controlled pump infusion systems after they are disconnected or decoupled from the first disposable electronically controlled infusion pump system. The disclosure further relates to a method for delivering infusion fluid to a patient utilizing the disposable electronically controlled infusion pump system, the non-disposable microcontroller, and the interface.
Existing infusion systems typically utilize bulky and complex electromechanical pump devices, which range from five pounds in weight up to 18 lbs., for large volume drug delivery. These electromechanical pump devices are large in size, heavy, require special mounting and handling hardware, are noisy, and are difficult to sterilize. Utilization of these electromechanical pump devices requires a substantial capital investment in procurement and periodic maintenance. Moreover, these electromechanical pump devices require the availability of adequate electric power and batteries. Other existing infusion systems may experience additional issues.
An infusion system and method is needed to reduce or eliminate one or more issues of one or more of the existing infusion systems.
In one embodiment, a disposable electronically controlled infusion pump system includes at least one disposable infusion container and a disposable electronically controlled medication pumping system. The at least one disposable infusion container is configured to contain infusion fluid. The disposable electronically controlled medication pumping system is fluidly connected to the at least one disposable infusion container. The disposable electronically controlled medication pumping system includes an infusion channel, a disposable electronically controlled micropump, air in line sensors, and active valves for pumping, and may further include a microprocessor, a memory, a battery or power receiver configured to wirelessly receive power, a wireless communication device, and other components. The memory is in electronic communication with the microprocessor. The wireless communication device is configured to receive a wireless signal which wirelessly controls the disposable electronically controlled medication pumping system. The disposable electronically controlled micropump is configured to pump the infusion fluid through the infusion channel. The valves are operably connected to the infusion channel to sequence and control the flow.
In another embodiment, an infusion pump system includes a non-disposable microcontroller, at least one disposable infusion container, and at least one disposable electronically controlled medication pumping system. The non-disposable microcontroller includes a first microprocessor, a first memory in electronic communication with the first microprocessor, a battery or power source, a power transmitter connected to the battery or power source and configured to transmit power, and a first wireless communication device. The at least one disposable infusion container is configured to contain infusion fluid. The at least one disposable electronically controlled medication pumping system, controlled by the non-disposable microcontroller, is fluidly connected to the at least one disposable infusion container. The at least one disposable electronically controlled medication pumping system includes a second microprocessor, a second memory in electronic communication with the second microprocessor, a power receiver configured to wirelessly receive power from the power transmitter, a second wireless communication device configured to wirelessly communicate with the first wireless communication device, an infusion channel, a disposable electronically controlled micropump configured to pump the infusion fluid through the infusion channel, air in line sensor and valves operably connected to the infusion channel to control or sequence the flow.
In another embodiment, an infusion pump system includes a non-disposable microcontroller, at least one disposable infusion container, and at least one disposable electronically controlled medication pumping system. The non-disposable microcontroller includes a first microprocessor, a first memory in electronic communication with the first microprocessor, a battery or other power source, a power transmitter connected to the power source and configured to transmit power, and a first wireless communication device. The at least one disposable infusion container is configured to contain infusion fluid. The at least one disposable electronically controlled medication pumping system, controlled by the non-disposable microcontroller, is a ganged system fluidly connected to the at least one disposable infusion container. The at least one disposable electronically controlled medication pumping system includes an infusion channel, at least two disposable electronically controlled micropumps configured to pump the infusion fluid through the infusion channel, and valves operably connected to the infusion channel. The at least one medication pumping system may also include a second microprocessor, a second memory in electronic communication with the second microprocessor, a power receiver configured to receive power from the power transmitter, a second wireless communication device configured to wirelessly communicate with the first wireless communication device, and other components. Other of at least one disposable electronically controlled medication pumping systems may further include a third microprocessor, a third memory in electronic communication with the third microprocessor, a power receiver configured to receive power from the power transmitter, a third wireless communication device configured to wirelessly communicate with the first wireless communication device or the second wireless communication device.
In still another embodiment, a method is disclosed for delivering infusion fluid from an electronically controlled infusion system. In one step, a disposable infusion fluid delivery device is provided including at least one disposable infusion container and a disposable electronically controlled medication pumping system. In another step, a pre-determined amount of infusion fluid is disposed into the at least one disposable infusion container. In an additional step, the disposable infusion fluid delivery device containing the infusion fluid in the at least one disposable infusion container is delivered to a location at which the patient is located. In yet another step, the disposable electronically controlled medication pumping system of the disposable infusion fluid delivery device is wirelessly controlled and wirelessly powered with a non-disposable microcontroller to infuse the infusion fluid from the disposable infusion container of the disposable infusion fluid delivery device. In another step, the disposable infusion fluid delivery device is disposed of after the infusion fluid is infused so that the disposable infusion fluid delivery device is only used one time, for a single patient,
The scope of the present disclosure is defined solely by the appended claims and is not affected by the statements within this summary.
The disclosure can be better understood with reference to the following drawings and description. The components in the figures are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the disclosure.
For purposes of this disclosure, the term “disposable” means used once for a particular patient and then disposed of (i.e. thrown away or destroyed). For purposes of this disclosure, the term “disposable” means that the component is made of a disposable material such as plastic or another inexpensive material, which is only needed for single patient, one-time use and will not have to be sterilized after first use due to its disposal instead of re-use for the same or different (multiple) patients. For purposes of this disclosure, the term “non-disposable” means that the component will be repeatedly used for the infusion of infusion fluid to the same or varying patients. Disposable items are sometimes used in the medical field because those items come in contact with hazardous medical fluids or bodily fluids. Disposable items can be disposed of rather than being used beyond the recommended time on a given patient or on a different patient with the risk of cross-contamination, infections, or other reactions. Non-disposable items are advantageously reusable with proper isolation, cleaning, disinfection, or sterilization between uses on the same or different patients. In the case of uses on different patients, isolation, cleaning, disinfecting, or sterilizing an item between uses can help reduce the likelihood of transmission of germs, staff, bacteria or other contamination, but can be difficult to accomplish completely or effectively.
The interface 12 comprises a device which is configured to interface with the non-disposable microcontroller 14 in order to power and electronically control the non-disposable microcontroller 14 which in turn powers and electronically controls the disposable infusion fluid delivery device 16. In other embodiments, the interface 12 may be used to only power or to only electronically control the non-disposable microcontroller 14 which in turns powers and/or electronically controls the disposable infusion fluid delivery device 16. The interface 12 may comprise a smartphone, a laptop, a stand-alone computer, a nurse station, an infusion pump, or another type of device. The interface 12 may be in wired or wireless communication with the non-disposable microcontroller 14.
In one embodiment, the non-disposable microcontroller 14 and the disposable infusion fluid delivery device 16 are not configured to work at all until the non-disposable microcontroller 14 is connected to the interface 12. In another embodiment, the system 10 may be configured to operate without the interface 12 with the non-disposable microcontroller 14 exclusively powering and/or electronically controlling the disposable infusion fluid delivery device 16. The interface 12 and the non-disposable microcontroller 14 are configured to be used as many times as needed (i.e. non-disposable for repeated use) to electronically power and control differing disposable infusion fluid delivery devices 16 to deliver infusion fluid to varying patients without the interface 12 or the non-disposable microcontroller 14 ever coming into contact with either the disposable infusion fluid delivery device 16 or the infusion fluid delivered by the disposable infusion fluid delivery device 16.
The disposable infusion fluid delivery device 16, which contains a programmed pre-determined amount and type of infusion fluid for a particular patient, is configured to be a stand-alone device which is only used for the particular patient and then disposed of immediately after use. Due to the disposable infusion fluid delivery device 16 never coming into contact with either the interface 12 or the non-disposable microcontroller 14, neither the interface 12 nor the non-disposable microcontroller 14 need to be sterilized. Additionally, since the disposable infusion fluid delivery device 16 is disposed of immediately after use on the particular patient it was intended for, it also does not need to be sterilized after use. As a result, significant time and cost involved in sterilization is saved, in addition to decreasing the health risk which is typically associated with sterilization deficiencies.
The non-disposable microcontroller 14 comprises a first microprocessor 18, a first memory 20, a first wireless communication device 22, a power transmitter 24, a power source 26 such as A/C and/or a battery, and a multiplexer 28. The first processor 18 is in communication with each of the first memory 20, the first wireless communication device 22, the power transmitter 24, the battery 26, and the multiplexer 28. In other embodiments, the components of the non-disposable microcontroller 14 may vary in configuration, type, or function.
The disposable infusion fluid delivery device 16 comprises at least one disposable infusion container 30, a seal 32, a temperature sensor 33, air in line sensor, flow sensor, active valves and a disposable medication pumping system 34. In other embodiments, the components of the disposable infusion fluid delivery device 16 may vary in configuration, type, or function. The disposable medication pumping system 34 comprises a second microprocessor 36, a second memory 38, a second wireless communication device 40, a power receiver 42, an infusion channel 44, a micropump 45, valves 46, one or more piezo actuators 48, a pressure detection sensor 50, a flow detection sensor 52, an air detection sensor 54, an optional one-dimensional, two-dimensional, holographic or other type of barcode 56, and a Radio Frequency Identification Tag 58. The second processor 36 is in communication with each of the temperature sensor 33, the second memory 38, the second wireless communication device 40, the power receiver 42, the micropump 45, the active valves 46, the piezo actuators 48, the pressure detection sensor 50, the flow detection sensor 52, the air detection sensor 54, the barcode 56, and the Radio Frequency Identification Tag 58. In other embodiments, the components of the disposable medication pumping system 34 may vary in configuration, type, or function. The disposable infusion fluid delivery device 16 may comprise an integral sealed cartridge containing all components of the disposable infusion fluid delivery device 16. In other embodiments, the disposable infusion fluid delivery device 16 and its components may vary in configuration, type, or function.
In one embodiment, the non-disposable microcontroller 14 has a size in a range of 9×6 cm and a weight in a range of 100-200 grams. In another embodiment, the non-disposable microcontroller 14 has a size in a range of 6×4 cm and a weight in a range of 50-100 grams. In still another embodiment, the non-disposable microcontroller 14 has a size in a range of 5×3 cm and a weight in a range of 25-50 grams. In other embodiments, the size and weight of the non-disposable microcontroller 14 may vary.
The first microprocessor 18 operates based on programming instructions and data saved in the first memory 20. The programming instructions and data saved in the first memory 20 may be pre-stored, or obtained from any source in the hospital information system, for example through interface 12. The programming instructions and data can be obtained from the second memory 38 of the disposable infusion fluid delivery device 16, from the temperature sensor 33, from the pressure detection sensor 50, from the flow detection sensor 52, from the air detection sensor 54, from the barcode 56, from the Radio Frequency Identification Tag 58, or obtained from another source. The programming instructions and data may have been set-up in in the first memory 20 or in the second memory 38 by the drug preparer (i.e., the pharmacy) based on the patient's drug prescription from a doctor. In other embodiments, a doctor or other medical provider may set-up this information into the first memory 20 or into the second memory 38 of the disposable infusion fluid delivery device 16. In still other embodiments, the programming instructions and data may have been set-up in in the first memory 20 or in the second memory 38 in varying ways.
This data may comprise any combination of the following information: a name or identification of the drug preparer that prepared the infusion fluid contained in the disposable infusion fluid delivery device 16 (this could be a drug manufacturer, pharmacy or a compounder of the infusion fluid); a date the infusion fluid was placed into or added to the disposable infusion fluid delivery device 16; a date the infusion fluid contained in the disposable infusion fluid delivery device 16 is to expire; a manufacturing date, serial number, storage information (temperature/time) a time related to the infusion of the infusion fluid contained in the disposable infusion fluid delivery device 16; an identification of the infusion fluid contained in the disposable infusion fluid delivery device 16; a drug identification of the infusion fluid contained in the disposable infusion fluid delivery device 16, which may include a drug name and concentration, a drug identification number, and diluent information; a volume of the infusion fluid contained in the infusion delivery device 16 to be infused into the patient, or a volume of the infusion fluid infused into the patient; a flow rate (programmed and/or actual) of the infusion fluid; a duration or delivery time of the infusion fluid; a power status and/or used or remaining battery capacity of the interface 12, of the non-disposable microcontroller 14, or of the disposable infusion fluid delivery device 16; a charging status of the interface 12, of the non-disposable microcontroller 14, or of the disposable infusion fluid delivery device 16; an identification or name of the patient; a RX order number or order ID; a therapy start time; a therapy end time; a delivery time; one or more alarm conditions; a flow sensor output (flow rate); a pressure sensor output (pressure); an air-in-line sensor output (single bubble or cumulative air volume); temperature data; data regarding parameters for infusion of the infusion fluid for the particular patient; or other types of information.
The first wireless communication device 22 is configured to wirelessly communicate with the second wireless communication device 40 to allow the non-disposable microcontroller 14 and the disposable infusion fluid delivery device 16 to communicate with one another. In one embodiment, the first wireless communication device 22 and the second wireless communication device 40 may comprise a Near-Field communication device. In other embodiments, the first wireless communication device 22 and the second wireless communication device 40 may vary in type or configuration. The power transmitter 24 is configured to wirelessly transmit power or energy to the power receiver 42 (which may comprise a battery) of the disposable infusion fluid delivery device 16 in order to power the operation of disposable infusion fluid delivery device 16. In one embodiment, the power or energy transmitter 24 may utilize Near-Field Charging (capacitive, inductive energy charging) to wirelessly charge the power receiver 42. In other embodiments, the power transmitter 24 may charge the power receiver 42 utilizing varying charging methods.
The power source 26 (in non-disposable controller) is configured in one embodiment as one or more disposable or rechargeable batteries that store electrical energy and provide energy to the power transmitter 24. The multiplexer 28 is configured to electronically and wirelessly control a plurality of the disposable electronically controlled medication pumping systems 34 (only one disposable electronically controlled medication pumping system 34 is shown in
The at least one disposable infusion container 30 is configured to contain infusion fluid. At least one hermetic seal 32 permanently seals the at least one disposable infusion container 30 to the disposable medication pumping system 34 so that after the drug preparer (manufacturer or pharmacy) disposes the infusion fluid within the at least one disposable infusion container 30 no one else comes in contact with the infusion fluid other than the patient since the disposable infusion fluid delivery device 16 is disposed of after the one-time use for the intended patient. The temperature sensor 33 keeps track of a temperature the disposable infusion fluid delivery device 16 is exposed to throughout its lifetime so that it is ensured that a temperature range requirement for the infusion fluid was not violated during storage, shipping or handling prior to infusion. If the temperature range was violated during the storage or transportation of the disposable infusion container, the infusion would not be permitted. Any of the interface 12, the non-disposable microcontroller 14, and the disposable infusion fluid delivery device 16 may be configured to analyze data emulating from the temperature sensor and to compare it to pre-set temperature parameters regarding the infusion fluid in order to ensure the temperature range requirement for the infusion fluid was not violated, and if it was, to prevent infusion of the infusion fluid.
In one embodiment, the micropump disclosed in US 2011/0005606 to Bartels et al., which is hereby incorporated by reference, may be used for the disposable electronically controlled micropump 45. The disposable electronically controlled micropump 45 may contain a plurality of electrically activated piezo-actuators 48 to control the pumping of infusion fluid through the infusion channel 44. In one embodiment, the disposable electronically controlled micropump 45 is configured to pump in a range of between 0.1 to 350 milliliters of the infusion fluid per hour with accuracy of +/−10% or better. In one embodiment, the disposable electronically controlled micropump 45 has a size in a range of 8×4 cm and a weight in a range of 50-100 grams. In another embodiment, the disposable electronically controlled micropump 45 has a size in a range of 5×3 cm and a weight in a range of 30-50 grams. In still another embodiment, the disposable electronically controlled micropump 45 has a size in a range of 4×2 cm and a weight in a range of 20-40 grams. In other embodiments, the size and weight of the disposable electronically controlled micropump 45 may vary. The disposable pump can be packaged in a packaging that is capable of providing hermiticity and is compliant with FDA approved materials and capable of withstanding necessary sterilization methods including gamma irradiation, EtO, E-beam, and steam sterilization.
The second microprocessor 36 operates based on programming instructions and data saved in the second memory 38. The programming instructions and data saved in the second memory 38 may be pre-stored, or obtained from any source in the hospital information system, for example through interface 12. The programming instructions and data can be obtained from the first memory 20 of the disposable infusion fluid delivery device 16, from the temperature sensor 33, from the pressure detection sensor 50, from the flow detection sensor 52, from the air detection sensor 54, from the barcode 56, from the Radio Frequency Identification Tag 58, or obtained from another source.
This data may comprise any combination of the following information: a name or identification of the drug preparer that prepared the infusion fluid contained in the disposable infusion fluid delivery device 16; a date the infusion fluid was disposed in the disposable infusion fluid delivery device 16; a date the infusion fluid contained in the disposable infusion fluid delivery device 16 is to expire; a time related to the infusion of the infusion fluid contained in the disposable infusion fluid delivery device 16; an identification of the infusion fluid contained in the disposable infusion fluid delivery device 16; a drug identification of the infusion fluid contained in the disposable infusion fluid delivery device 16; a volume of the infusion fluid contained in the infusion delivery device 16 to be infused into the patient, or a volume of the infusion fluid infused into the patient; a flow rate of the infusion fluid; a delivery time of the infusion fluid; a power status of the interface 12, of the non-disposable microcontroller 14, or of the disposable infusion fluid delivery device 16; a charging status of the interface 12, of the non-disposable microcontroller 14, or of the disposable infusion fluid delivery device 16; an identification or name of the patient; a RX order number; a therapy start time; a therapy end time; a delivery time; one or more alarm conditions; a flow sensor output (flow rate); a pressure sensor output (pressure); an air-in-line sensor output (single bubble or cumulative air volume); temperature data; data regarding parameters for infusion of the infusion fluid for the particular patient; or other types of information. The data can be in the form of near real-time logs of the infusion delivery device's operation.
The infusion channel 44 is configured so that the infusion fluid from the at least one disposable infusion container 30 is flowed or pumped through the infusion channel 44 to the patient. The valves 46 are operatively connected to the infusion channel 44 and, along with the micropump 45, control the flow of the infusion fluid through the infusion channel 44. The valves 46 may comprise passive or active input and output valves controlled by the first microprocessor 18 or the second microprocessor 36. Use of active valves provides inherent free-flow protection and reduces the impact of backpressure and head height variability thus assuring flow rate accuracy. In other embodiments, varying types and configurations of valves 46 may be utilized.
The pressure detection sensor 50 is configured to determine a pressure of the infusion fluid flowing through the infusion channel 44 to provide real-time feedback regarding the infusion fluid pressure. In one embodiment the pressure sensor is downstream or distal with respect to the micropump 45. The flow detection sensor 52 is configured to determine a flow rate of the infusion fluid flowing through the infusion channel 44 to provide real-time feedback regarding delivery accuracy. The air detection sensor 54 is configured to determine a quantity of air in the infusion fluid flowing through the infusion channel 44 to provide real time feedback regarding the air in the infusion fluid.
The barcode 56 provides information regarding the infusion fluid, the particular patient the infusion fluid is intended for, or other information regarding the patient, the infusion fluid, and/or its delivery. The Radio Frequency Identification Tag 58 provides information such as: drug lot; program details; patient information; pump lot; pharmacy information; day and time; or other information regarding the patient, the infusion fluid, and/or its delivery.
Any of the interface 12, the non-disposable microcontroller 14, and the disposable infusion fluid delivery device 16 may be configured to analyze the information provided by the barcode 56 and/or the Radio Frequency Identification Tag 58, to analyze information stored in the first memory 20 or the second memory 38 regarding the infusion fluid, its delivery, or the particular patient, to analyze information sensed by the temperature sensor 33, the pressure detection sensor 50, the flow detection sensor 52, or the air detection sensor 54, or to analyze other information provided from other sources regarding the infusion fluid, its delivery, or the particular patient in order to ensure that patient and infusion delivery parameters are met. This may include making sure that the right infusion fluid is being infused into the right patient, making sure that the infusion fluid is infused using the correct parameters (i.e. time, flow-rate, pressure, air-prevention, temperature, amount delivered, etc.), preventing the disposable infusion fluid device 16 from being reused after it has been used on the intended patient, or ensuring that other patient and/or infusion delivery parameters are followed. If the interface 12, the non-disposable microcontroller 14, or the disposable infusion fluid delivery device 16 determine that the appropriate patient and/or infusion delivery parameters are not being followed they may be configured to adjust the infusion delivery to ensure compliance with these restraints and/or to provide an alert, alarm or stop the infusion.
For example, in the embodiment shown in
This information may comprise drug lot, program details, patient information, pump lot, pharmacy information, day and time, or other information regarding the patient, the infusion fluid, and/or its delivery. This information may further comprise any combination of the following information: a name or identification of the drug preparer that prepared the infusion fluid contained in the disposable infusion fluid delivery device; a date the infusion fluid was disposed in the disposable infusion fluid delivery device; a date the infusion fluid contained in the disposable infusion fluid delivery device is to expire; a time related to the infusion of the infusion fluid contained in the disposable infusion fluid delivery device; an identification of the infusion fluid contained in the disposable infusion fluid delivery device; a drug identification of the infusion fluid contained in the disposable infusion fluid delivery device; a volume of the infusion fluid contained in the infusion delivery device to be infused into the patient, or a volume of the infusion fluid infused into the patient; a flow rate of the infusion fluid; a delivery time of the infusion fluid; a power status of the interface, of the non-disposable microcontroller, or of the disposable infusion fluid delivery device; a charging status of the interface, of the non-disposable microcontroller, or of the disposable infusion fluid delivery device; an identification or name of the patient; a RX order number; a therapy start time; a therapy end time; a delivery time; one or more alarm conditions; a flow sensor output (flow rate); a pressure sensor output (pressure); an air-in-line sensor output (cumulative air volume); data regarding parameters for infusion of the infusion fluid for the particular patient; or other types of information.
In step 78 the disposable infusion fluid delivery device containing the infusion fluid disposed in the at least one disposable infusion container is delivered from the drug preparer to a location at which the patient is located. In step 80, at the location at which the patient is located, the non-disposable microcontroller, with or without connection to an interface communicates with the disposable infusion fluid delivery device. In step 82 the information of the barcode or the Radio Frequency Identification Tag attached to the disposable infusion fluid delivery device, information contained in the second memory of the disposable infusion fluid delivery device, information contained in the first memory of the non-disposable microcontroller, or other information contained in another memory is wirelessly communicated to and/or read by the non-disposable microcontroller or the disposable infusion fluid delivery device microcontroller as the desired direction of the communication or information flow dictates. In step 84 the disposable electronically controlled medication pumping system of the disposable infusion fluid delivery device is wirelessly controlled and wirelessly powered with the non-disposable microcontroller to infuse the infusion fluid from the disposable infusion container of the disposable infusion fluid delivery device into the patient.
In one embodiment, in step 84 the non-disposable microcontroller wirelessly controls the disposable infusion fluid delivery device to infuse the infusion fluid into the patient utilizing the information of the barcode or the Radio Frequency Tag, utilizing the information saved in the first memory of the non-disposable microcontroller or the second memory of the disposable infusion fluid delivery device, utilizing information saved in another memory, or utilizing other information regarding the infusion fluid, its delivery, or the particular patient to which the infusion fluid is being infused.
In one embodiment, in step 84 any of the interface, the non-disposable microcontroller, and the disposable infusion fluid delivery device may analyze the information provided by the barcode and/or the Radio Frequency Identification Tag, to analyze information stored in the first memory or the second memory regarding the infusion fluid, its delivery, or the particular patient, to analyze information sensed by the temperature sensor, the pressure detection sensor, the flow detection sensor, or the air detection sensor, or to analyze other information provided from other sources regarding the infusion fluid, its delivery, or the particular patient in order to ensure that patient, infusion fluid conditions such as age, storage/transit/delivery temperature, and the like, and infusion delivery parameters are met.
For instance this may include ensuring that the temperature range requirements for the infusion fluid have been followed during storage, shipment and delivery, ensuring that the infusion fluid is being infused into the right patient, ensuring that the infusion fluid is infused using the correct parameters (i.e. time, flow-rate, pressure, air-prevention, temperature, amount delivered, etc.), ensuring that the disposable infusion fluid device is not reused after it has been used on the intended patient, or ensuring that other patient and/or infusion delivery parameters are followed. If the interface, the non-disposable microcontroller, or the disposable infusion fluid delivery device determine that the appropriate patient and/or infusion delivery parameters are not being followed they may be configured to adjust the infusion delivery to ensure compliance with these restraints, provide an alert or alarm signal, and/or to stop the infusion.
In step 86 a log of the disposable infusion fluid delivery device, regarding the infusion of the infusion fluid to the patient, is wirelessly communicated from the disposable infusion fluid delivery device to the non-disposable microcontroller. In step 88 the disposable infusion fluid delivery device is disposed of after the medication is infused into the patient so that the disposable infusion fluid delivery device is only used for a single patient and single delivery before its disposal.
In step 90 the method is repeated using new disposable infusion fluid delivery devices with the interface and the non-disposable microcontroller being used to wirelessly control and wirelessly power the new disposable infusion fluid delivery devices to infuse infusion fluid contained in the new disposable infusion fluid delivery devices to the same or different patients on a one-time basis, after which the new disposable infusion fluid delivery devices are disposed of. Since the interface and the non-disposable microcontroller never came into contact with the disposable infusion fluid delivery device, the infusion fluid itself, or the bodily fluids of patients, no sterilization of the interface or the non-disposable microcontroller is necessary.
In one embodiment, an additional step of the method 70 may comprise a multiplexer of the non-disposable microcontroller concurrently electronically and wirelessly controlling a plurality of disposable infusion fluid delivery devices, each comprising at least one disposable infusion container and a disposable electronically controlled medication pumping system, to deliver different infusion fluids to the patient or to provide a redundant system.
In another embodiment suggested in view of
In one embodiment, the interface utilized in the method 70 comprises a smartphone, a laptop, a stand-alone computer, a nurse station, an infusion pump, or another type of device. In one embodiment, the non-disposable microcontroller utilized in the method 70 comprises a first microprocessor, a first memory in electronic communication with the first microprocessor, a battery, a power transmitter configured to wirelessly transmit power, and a first wireless communication device. In one embodiment, the disposable electronically controlled medication pumping system of the disposable infusion fluid delivery device utilized in the method 70 comprises a second microprocessor, a second memory in electronic communication with the second microprocessor, a power receiver configured to wirelessly receive power from the power transmitter, a second wireless communication device configured to wirelessly communicate with the first wireless communication device, an infusion channel, a disposable electronically controlled micropump, and valves connected to the infusion channel.
In other embodiments, the interface, the non-disposable microcontroller, and the disposable infusion fluid delivery device may vary. In still other embodiments, any of the steps of the method 70 may be eliminated or changed in substance or in order, or one or more additional steps may be added in varying orders.
The systems and methods of the disclosure provide many benefits over existing infusion systems. For instance, substantial cost is saved in the manufacture of the infusion systems of the disclosure due to the use of the inexpensive disposable electronically controlled micropump which requires a fraction of the power required to run current infusion systems. Moreover, since the disposable infusion fluid delivery devices of the disclosure are sealed, delivered in a sterilized state, and only used once for a single patient and then disposed of, cleaning cost are effectively eliminated and the risk to medical personnel from being exposed to the infusion fluid is similarly substantially eliminated. Additionally, the infusion systems of the disclosure are substantially smaller in weight and size than current infusion systems. These factors reduce shipping and storage cost, and make the infusion system easier to handle and interface with. Further, the infusion systems of the disclosure have significant noise reduction over current infusion systems due to the small disposable micropumps.
Moreover, the small size of the disposable infusion fluid delivery devices of the disclosure reduces the risk of over-exposure to the infusion fluid. Smaller and more concentrated amounts of the costly infusion fluids can be delivered. Additionally, the infusion systems of the disclosure utilize a multiplexed controller which allows multiple drug infusions simultaneously. Further, the disposable infusion fluid delivery devices of the disclosure can be shipped for medical control, i.e. insulin and glucose, in a single pumping mechanism. The infusion systems of the disclosure cover all therapies given via current technology and many others including: blood clotting (heparin and coagulant); blood pressure and heart rate control; oxygenation, SPO2 (saturation of peripheral oxygen); renal failure prevention (protect kidney); fluid volume balance; PCA (patient controlled analgesia)/cardiac arrest; and others. Additionally, the infusion systems of the disclosure provide for automatic data capture, recording, and near real-time feedback regarding the infusion delivery and the patient to ensure that the required parameters for the infusion are met in order to improve reliability and accuracy. Additionally, the infusion system allows configuration of highly redundant medication delivery system, which is impractical or very difficult to achieve using current pump technology.
The Abstract is provided to allow the reader to quickly ascertain the nature of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims. In addition, in the foregoing Detailed Description, it can be seen that various features are grouped together in various embodiments for the purpose of streamlining the disclosure. This method of disclosure is not to be interpreted as reflecting an intention that the claimed embodiments require more features than are expressly recited in each claim. Rather, as the following claims reflect, inventive subject matter lies in less than all features of a single disclosed embodiment. Thus the following claims are hereby incorporated into the Detailed Description, with each claim standing on its own as a separately claimed subject matter.
While particular aspects of the present subject matter described herein have been shown and described, it will be apparent to those skilled in the art that, based upon the teachings herein, changes and modifications may be made without departing from the subject matter described herein and its broader aspects and, therefore, the appended claims are to encompass within their scope all such changes and modifications as are within the true scope of the subject matter described herein. Furthermore, it is to be understood that the disclosure is defined by the appended claims. Accordingly, the disclosure is not to be restricted except in light of the appended claims and their equivalents.
This application is a continuation of U.S. patent application Ser. No. 17/142,823, filed Jan. 6, 2021, which is a divisional of U.S. patent application Ser. No. 15/164,277, filed on May 25, 2016, which claims the benefit of U.S. Provisional Application Ser. No. 62/166,422, filed on May 26, 2015, each of which are hereby incorporated by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
790353 | Estlingen | May 1905 | A |
1248058 | Bailey | Nov 1917 | A |
1576445 | Mitchell | Mar 1926 | A |
1647039 | Fischer | Apr 1927 | A |
1749491 | Kokay | Apr 1930 | A |
2820886 | Posey | May 1955 | A |
2869690 | Winters et al. | Jan 1959 | A |
2903165 | Hanson et al. | Sep 1959 | A |
3185153 | Leucci | May 1965 | A |
3316935 | Kaiser et al. | May 1967 | A |
3367270 | Schlosser | Feb 1968 | A |
3427986 | Corneil | Feb 1969 | A |
3606596 | Edwards | Sep 1971 | A |
3647176 | Usry | Mar 1972 | A |
3650296 | Johnson et al. | Mar 1972 | A |
3771862 | Land et al. | Nov 1973 | A |
3777581 | Sartori | Dec 1973 | A |
3812482 | Clark | May 1974 | A |
3898637 | Wolstenholme | Aug 1975 | A |
3901231 | Olson | Aug 1975 | A |
3913384 | Furuya | Oct 1975 | A |
3921622 | Cole | Nov 1975 | A |
3935876 | Massie et al. | Feb 1976 | A |
3985133 | Jenkins et al. | Oct 1976 | A |
4068521 | Cosentino et al. | Jan 1978 | A |
4155362 | Jess | May 1979 | A |
4187057 | Xanthopoulos | Feb 1980 | A |
4193635 | Thiruvengadam et al. | Mar 1980 | A |
4195515 | Smoll | Apr 1980 | A |
4211380 | Lillegard et al. | Jul 1980 | A |
4213454 | Shim | Jul 1980 | A |
4223813 | Garrett et al. | Sep 1980 | A |
4236880 | Archibald | Dec 1980 | A |
4240294 | Grande | Dec 1980 | A |
4244365 | McGill | Jan 1981 | A |
4261356 | Turner et al. | Apr 1981 | A |
4291701 | Bowman et al. | Sep 1981 | A |
4303376 | Siekmann | Dec 1981 | A |
4332378 | Pryor | Jun 1982 | A |
4343316 | Jespersen | Aug 1982 | A |
4381591 | Barger et al. | May 1983 | A |
4397642 | Lamadrid | Aug 1983 | A |
4397648 | Knute et al. | Aug 1983 | A |
4406042 | McPhee et al. | Sep 1983 | A |
4418565 | St. John | Dec 1983 | A |
4439179 | Lueders et al. | Mar 1984 | A |
4468222 | Lundquist | Aug 1984 | A |
4469765 | McCartney et al. | Sep 1984 | A |
4482347 | Borsanyi | Nov 1984 | A |
4496351 | Hillel et al. | Jan 1985 | A |
4513885 | Hogan | Apr 1985 | A |
4528847 | Halmi | Jul 1985 | A |
4530647 | Uno | Jul 1985 | A |
4551134 | Slavik et al. | Nov 1985 | A |
4565500 | Jeensalute et al. | Jan 1986 | A |
4573968 | Parker | Mar 1986 | A |
4585441 | Archibald et al. | Apr 1986 | A |
4586691 | Kozlow | May 1986 | A |
4589171 | McGill et al. | May 1986 | A |
4607520 | Dam | Aug 1986 | A |
4613325 | Abrams | Sep 1986 | A |
4626243 | Singh et al. | Dec 1986 | A |
4626244 | Reinicke | Dec 1986 | A |
4644960 | Johans | Feb 1987 | A |
4680977 | Conero et al. | Jul 1987 | A |
4681563 | Deckert et al. | Jul 1987 | A |
4683916 | Raines | Aug 1987 | A |
4689043 | Bisha | Aug 1987 | A |
4694273 | Franchino | Sep 1987 | A |
4696671 | Epstein et al. | Sep 1987 | A |
4722725 | Sawyer | Feb 1988 | A |
4728265 | Cannon | Mar 1988 | A |
4735558 | Kienholz et al. | Apr 1988 | A |
4756706 | Kerns et al. | Jul 1988 | A |
4758228 | Williams | Jul 1988 | A |
4759749 | Verkaart | Jul 1988 | A |
4802650 | Stricker | Feb 1989 | A |
4811928 | Iwatschenko et al. | Mar 1989 | A |
4813280 | Miller et al. | Mar 1989 | A |
4820281 | Lawler | Apr 1989 | A |
4828545 | Epstein et al. | May 1989 | A |
4832299 | Gorton et al. | May 1989 | A |
4840345 | Neil et al. | Jun 1989 | A |
4842584 | Pastrone et al. | Jun 1989 | A |
4844397 | Skakoon et al. | Jul 1989 | A |
4845487 | Frantz et al. | Jul 1989 | A |
4846636 | Danby et al. | Jul 1989 | A |
4856339 | Williams | Aug 1989 | A |
4857048 | Simons et al. | Aug 1989 | A |
4857050 | Lentz et al. | Aug 1989 | A |
4858548 | Echeverria | Aug 1989 | A |
4865584 | Epstein et al. | Sep 1989 | A |
4881413 | Georgi et al. | Nov 1989 | A |
D305060 | Bisha′ et al. | Dec 1989 | S |
4892656 | Pietzsch | Jan 1990 | A |
4898578 | Rubalcaba, Jr. | Feb 1990 | A |
4925444 | Orkin et al. | May 1990 | A |
4927411 | Pastrone et al. | May 1990 | A |
4935014 | Haber | Jun 1990 | A |
4938079 | Goldberg | Jul 1990 | A |
4947856 | Beard | Aug 1990 | A |
5014798 | Glynn | May 1991 | A |
5017192 | Dodge et al. | May 1991 | A |
5031465 | Redus | Jul 1991 | A |
5034004 | Crankshaw | Jul 1991 | A |
5062775 | Orth | Nov 1991 | A |
5085644 | Watson et al. | Feb 1992 | A |
5098262 | Wecker et al. | Mar 1992 | A |
5102083 | Baskas | Apr 1992 | A |
5102392 | Sakai et al. | Apr 1992 | A |
5113904 | Aslanian | May 1992 | A |
5138743 | Hoffman | Aug 1992 | A |
5125891 | Hossain et al. | Sep 1992 | A |
5152753 | Laguette et al. | Oct 1992 | A |
5154513 | Beer et al. | Oct 1992 | A |
5163900 | Wortrich | Nov 1992 | A |
5165406 | Wong et al. | Nov 1992 | A |
5165873 | Meijer | Nov 1992 | A |
5169106 | Rasmussen | Dec 1992 | A |
5177993 | Beckman et al. | Jan 1993 | A |
5187746 | Narisawa | Feb 1993 | A |
5192269 | Poli et al. | Mar 1993 | A |
5205153 | Hlavinka et al. | Apr 1993 | A |
5207642 | Orkin et al. | May 1993 | A |
5211626 | Frank et al. | May 1993 | A |
5217355 | Hyman et al. | Jun 1993 | A |
5219099 | Spence et al. | Jun 1993 | A |
5219327 | Okada | Jun 1993 | A |
5219428 | Stern | Jun 1993 | A |
5220920 | Gharib | Jun 1993 | A |
5225063 | Gumbrecht et al. | Jul 1993 | A |
5242406 | Gross et al. | Sep 1993 | A |
5256157 | Samiotes et al. | Oct 1993 | A |
5257978 | Haber et al. | Nov 1993 | A |
5270702 | Krolak | Dec 1993 | A |
5271815 | Wong | Dec 1993 | A |
5282787 | Wortrich | Feb 1994 | A |
5287851 | Beran et al. | Feb 1994 | A |
5292306 | Wynkoop et al. | Mar 1994 | A |
5302093 | Owens et al. | Apr 1994 | A |
5306122 | Gebauer et al. | Apr 1994 | A |
5309604 | Poulsen et al. | May 1994 | A |
5317506 | Coutre et al. | May 1994 | A |
D348101 | Poli et al. | Jun 1994 | S |
5322253 | Stevens | Jun 1994 | A |
5324266 | Ambrisco et al. | Jun 1994 | A |
5325728 | Zimmerman et al. | Jul 1994 | A |
5326059 | Pryor et al. | Jul 1994 | A |
5330634 | Wong et al. | Jul 1994 | A |
5332184 | Davis | Jul 1994 | A |
5345932 | Yafuso et al. | Sep 1994 | A |
5346466 | Yerlikaya et al. | Sep 1994 | A |
5358205 | Starkey et al. | Oct 1994 | A |
5364364 | Kasvikis et al. | Nov 1994 | A |
D353667 | Tsubota et al. | Dec 1994 | S |
5378126 | Abrahamson et al. | Jan 1995 | A |
5378231 | Johnson et al. | Jan 1995 | A |
5380665 | Cusack et al. | Jan 1995 | A |
5382232 | Hague et al. | Jan 1995 | A |
D355716 | Nash et al. | Feb 1995 | S |
5395320 | Padda et al. | Mar 1995 | A |
5401256 | Stone et al. | Mar 1995 | A |
5403277 | Dodge et al. | Apr 1995 | A |
5417119 | Smoll | May 1995 | A |
5417395 | Fowler et al. | May 1995 | A |
5421209 | Redus | Jun 1995 | A |
5421328 | Bedingham | Jun 1995 | A |
5431174 | Knute | Jul 1995 | A |
5431509 | Anderson et al. | Jul 1995 | A |
5431627 | Pastrone et al. | Jul 1995 | A |
5437635 | Fields et al. | Aug 1995 | A |
5445506 | Afflerbaugh et al. | Aug 1995 | A |
5445621 | Poli et al. | Aug 1995 | A |
5445622 | Brown | Aug 1995 | A |
5450758 | Smoll | Sep 1995 | A |
5453098 | Botts et al. | Sep 1995 | A |
5462052 | Gehrich | Oct 1995 | A |
5462256 | Minick et al. | Oct 1995 | A |
5463906 | Spani et al. | Nov 1995 | A |
5465938 | Werge et al. | Nov 1995 | A |
5482446 | Williamson et al. | Jan 1996 | A |
D367528 | Martson et al. | Feb 1996 | S |
5489265 | Montalvo et al. | Feb 1996 | A |
5489486 | Glover | Feb 1996 | A |
5505828 | Wong et al. | Apr 1996 | A |
5515713 | Saugues et al. | May 1996 | A |
5524475 | Kolpak | Jun 1996 | A |
5527289 | Foster et al. | Jun 1996 | A |
5538807 | Hagiuda | Jul 1996 | A |
5540561 | Johnson et al. | Jul 1996 | A |
5551300 | Vurek et al. | Sep 1996 | A |
5554013 | Owens et al. | Sep 1996 | A |
5554112 | Walbrink et al. | Sep 1996 | A |
D376199 | Rozek et al. | Dec 1996 | S |
5584671 | Schweitzer, Jr. et al. | Dec 1996 | A |
5586868 | Lawless et al. | Dec 1996 | A |
5601420 | Warner et al. | Feb 1997 | A |
5601445 | Schipper et al. | Feb 1997 | A |
5603613 | Butterfield et al. | Feb 1997 | A |
5609572 | Lang | Mar 1997 | A |
5611784 | Barresi et al. | Mar 1997 | A |
5616124 | Hague et al. | Apr 1997 | A |
5626151 | Linden | May 1997 | A |
5628309 | Brown | May 1997 | A |
5628731 | Dodge et al. | May 1997 | A |
5630710 | Tune et al. | May 1997 | A |
5647491 | Foster et al. | Jul 1997 | A |
5647852 | Atkinson | Jul 1997 | A |
5651775 | Walker et al. | Jul 1997 | A |
5657000 | Ellingboe | Aug 1997 | A |
5658133 | Anderson et al. | Aug 1997 | A |
5672832 | Cucci et al. | Sep 1997 | A |
5673588 | Raymond | Oct 1997 | A |
5681019 | Boyce | Oct 1997 | A |
5693891 | Brown et al. | Dec 1997 | A |
5697899 | Hillman et al. | Dec 1997 | A |
5697916 | Schraga | Dec 1997 | A |
5709663 | Younkes | Jan 1998 | A |
D390574 | Ashcraft | Feb 1998 | S |
D390654 | Alsberg et al. | Feb 1998 | S |
5713509 | Correll | Feb 1998 | A |
5713856 | Eggers et al. | Feb 1998 | A |
5718569 | Holst | Feb 1998 | A |
5723773 | Bryan | Mar 1998 | A |
5728069 | Montevecchi et al. | Mar 1998 | A |
5728074 | Castellano et al. | Mar 1998 | A |
5733061 | Child | Mar 1998 | A |
5736650 | Hiron et al. | Apr 1998 | A |
5738662 | Shannon et al. | Apr 1998 | A |
5740810 | Johnson et al. | Apr 1998 | A |
5745378 | Barker et al. | Apr 1998 | A |
D394440 | Chen | May 1998 | S |
5752918 | Fowler et al. | May 1998 | A |
5755563 | Clegg et al. | May 1998 | A |
5755683 | Houle et al. | May 1998 | A |
5758643 | Wong et al. | Jun 1998 | A |
5763760 | Gumbrecht et al. | Jun 1998 | A |
5772166 | Adams | Jun 1998 | A |
5772637 | Heinzmann et al. | Jun 1998 | A |
5782611 | Neftel et al. | Jul 1998 | A |
5782805 | Meinzer et al. | Jul 1998 | A |
5793216 | Constant | Aug 1998 | A |
5804048 | Wong et al. | Sep 1998 | A |
5805455 | Lipps | Sep 1998 | A |
5807345 | Grabenkort | Sep 1998 | A |
5812419 | Chupp et al. | Sep 1998 | A |
5814015 | Gargano et al. | Sep 1998 | A |
5816779 | Lawless et al. | Oct 1998 | A |
5848971 | Fowler et al. | Dec 1998 | A |
5853386 | Davis et al. | Dec 1998 | A |
5868696 | Giesler et al. | Feb 1999 | A |
5868710 | Battiato et al. | Feb 1999 | A |
5868712 | Briggs et al. | Feb 1999 | A |
5891051 | Han et al. | Apr 1999 | A |
5895371 | Levitas et al. | Apr 1999 | A |
5902253 | Pfeiffer et al. | May 1999 | A |
5904666 | DeDecker et al. | May 1999 | A |
5910808 | Fukasawa et al. | Jun 1999 | A |
5925022 | Battiato et al. | Jul 1999 | A |
5932175 | Knute et al. | Aug 1999 | A |
5935099 | Peterson et al. | Aug 1999 | A |
5938638 | Passariello et al. | Aug 1999 | A |
5939326 | Chupp et al. | Aug 1999 | A |
5941846 | Duffy et al. | Aug 1999 | A |
5944660 | Kimball et al. | Aug 1999 | A |
5947911 | Wong et al. | Sep 1999 | A |
5954485 | Johnson et al. | Sep 1999 | A |
5989222 | Cole et al. | Nov 1999 | A |
6004292 | Battiato et al. | Dec 1999 | A |
6007941 | Hermann et al. | Dec 1999 | A |
6017318 | Gauthier et al. | Jan 2000 | A |
6027445 | Von Bahr | Feb 2000 | A |
6027479 | Alei et al. | Feb 2000 | A |
6032536 | Peeters et al. | Mar 2000 | A |
D424692 | Monaghan et al. | May 2000 | S |
6056522 | Johnson | May 2000 | A |
6068615 | Brown et al. | May 2000 | A |
6080583 | Von Bahr | Jun 2000 | A |
6085574 | Neftel et al. | Jul 2000 | A |
6090071 | Kriesel et al. | Jul 2000 | A |
6099470 | Bahr | Aug 2000 | A |
6105442 | Kriesel et al. | Aug 2000 | A |
6106498 | Friedli et al. | Aug 2000 | A |
6109460 | Herlevi et al. | Aug 2000 | A |
6110153 | Davis | Aug 2000 | A |
6110410 | Owens et al. | Aug 2000 | A |
RE36871 | Epstein et al. | Sep 2000 | E |
6117290 | Say et al. | Sep 2000 | A |
6123827 | Wong et al. | Sep 2000 | A |
6165154 | Gray et al. | Dec 2000 | A |
6186752 | Deniega et al. | Feb 2001 | B1 |
6186977 | Andrews et al. | Feb 2001 | B1 |
6186983 | Von Bahr | Feb 2001 | B1 |
6203528 | Deckert | Mar 2001 | B1 |
6210361 | Kamen et al. | Apr 2001 | B1 |
6221065 | Davis | Apr 2001 | B1 |
6231320 | Lawless et al. | May 2001 | B1 |
6237398 | Porat et al. | May 2001 | B1 |
6250132 | Drzewiecki | Jun 2001 | B1 |
6254572 | Knipfer et al. | Jul 2001 | B1 |
6261262 | Briggs | Jul 2001 | B1 |
6269704 | Ziv et al. | Aug 2001 | B1 |
6270455 | Brown | Aug 2001 | B1 |
6272934 | Rajan et al. | Aug 2001 | B1 |
6277099 | Strowe et al. | Aug 2001 | B1 |
6285155 | Maske et al. | Sep 2001 | B1 |
6290681 | Brown | Sep 2001 | B1 |
6325264 | Omosako | Dec 2001 | B1 |
6349740 | Cho et al. | Feb 2002 | B1 |
D454884 | Christiansen et al. | Mar 2002 | S |
6364857 | Gray et al. | Apr 2002 | B1 |
6385505 | Lipps | May 2002 | B1 |
6386050 | Yin et al. | May 2002 | B1 |
6390120 | Guala | May 2002 | B1 |
6396583 | Clare | May 2002 | B1 |
6409707 | Guala | Jun 2002 | B1 |
6422256 | Balazy et al. | Jul 2002 | B1 |
6445053 | Cho | Sep 2002 | B1 |
6463394 | Von Bahr | Oct 2002 | B1 |
6464667 | Kamen et al. | Oct 2002 | B1 |
6478065 | Haberstroh et al. | Nov 2002 | B1 |
6482185 | Hartmann | Nov 2002 | B1 |
6488652 | Weijand et al. | Dec 2002 | B1 |
6489896 | Platt | Dec 2002 | B1 |
6494694 | Lawless et al. | Dec 2002 | B2 |
6503221 | Briggs | Jan 2003 | B1 |
6515487 | Dawson | Feb 2003 | B1 |
6519569 | White et al. | Feb 2003 | B1 |
6537258 | Guala | Mar 2003 | B1 |
6558125 | Futterknecht | May 2003 | B1 |
6565054 | Weesner et al. | May 2003 | B2 |
6568416 | Tucker et al. | May 2003 | B2 |
D475454 | Gillespie, Jr. et al. | Jun 2003 | S |
D475721 | Harper et al. | Jun 2003 | S |
6578435 | Gould et al. | Jun 2003 | B2 |
RE38189 | Walker et al. | Jul 2003 | E |
6595943 | Burbank | Jul 2003 | B1 |
6599746 | Gumbrecht | Jul 2003 | B1 |
6609047 | Lipps | Aug 2003 | B1 |
D479248 | Gist et al. | Sep 2003 | S |
6623470 | Munis et al. | Sep 2003 | B2 |
D481121 | Evans | Oct 2003 | S |
6635033 | Hill et al. | Oct 2003 | B1 |
6645142 | Braig et al. | Nov 2003 | B2 |
6656148 | Das et al. | Dec 2003 | B2 |
D485356 | Evans | Jan 2004 | S |
6672561 | Kerg et al. | Jan 2004 | B2 |
6685668 | Cho et al. | Feb 2004 | B1 |
6685670 | Miles et al. | Feb 2004 | B2 |
6685678 | Evans et al. | Feb 2004 | B2 |
6695803 | Robinson et al. | Feb 2004 | B1 |
6700174 | Mui et al. | Mar 2004 | B1 |
6700784 | Huang et al. | Mar 2004 | B2 |
6709417 | Houle et al. | Mar 2004 | B1 |
6722211 | Ciobanu et al. | Apr 2004 | B1 |
6726656 | Kamen et al. | Apr 2004 | B2 |
6726657 | Dedig et al. | Apr 2004 | B1 |
6736801 | Gallagher | May 2004 | B1 |
6749403 | Bryant et al. | Jun 2004 | B2 |
6755086 | Salamitou | Jun 2004 | B2 |
6755391 | Newton et al. | Jun 2004 | B2 |
6760643 | Lipps | Jul 2004 | B2 |
6813964 | Clark et al. | Nov 2004 | B1 |
D500326 | Fathallah et al. | Dec 2004 | S |
6827709 | Fujii | Dec 2004 | B2 |
6872297 | Mansouri et al. | Mar 2005 | B2 |
D504507 | Ziegler et al. | Apr 2005 | S |
6890315 | Levin et al. | May 2005 | B1 |
6905314 | Danby | Jun 2005 | B2 |
6915679 | Chien et al. | Jul 2005 | B2 |
6920795 | Bischoff et al. | Jul 2005 | B2 |
6929619 | Fago et al. | Aug 2005 | B2 |
6932796 | Sage et al. | Aug 2005 | B2 |
6935189 | Richards | Aug 2005 | B2 |
6935192 | Sobek et al. | Aug 2005 | B2 |
6939111 | Huitt et al. | Sep 2005 | B2 |
6942473 | Abrahamson et al. | Sep 2005 | B2 |
6942636 | Holst et al. | Sep 2005 | B2 |
6964204 | Clark et al. | Nov 2005 | B2 |
6969419 | Macemon | Nov 2005 | B1 |
6975922 | Duncan et al. | Dec 2005 | B2 |
6981960 | Cho et al. | Jan 2006 | B2 |
D515205 | Fathalla et al. | Feb 2006 | S |
7004727 | Kline et al. | Feb 2006 | B2 |
7008393 | Robinson et al. | Mar 2006 | B2 |
RE39075 | Verkaart | Apr 2006 | E |
7029105 | Matsuba et al. | Apr 2006 | B2 |
7037428 | Robinson et al. | May 2006 | B1 |
7041076 | Westberg et al. | May 2006 | B1 |
7044002 | Ericson et al. | May 2006 | B2 |
7059184 | Kanouda et al. | Jun 2006 | B2 |
7061766 | Wainwright et al. | Jun 2006 | B2 |
7070578 | Leukanech et al. | Jul 2006 | B2 |
7074209 | Evans et al. | Jul 2006 | B2 |
7077650 | Johnstone | Jul 2006 | B2 |
7082843 | Clark et al. | Aug 2006 | B2 |
7087036 | Busby et al. | Aug 2006 | B2 |
7096729 | Repko et al. | Aug 2006 | B2 |
7115113 | Evans et al. | Oct 2006 | B2 |
7140070 | Yuta et al. | Nov 2006 | B2 |
7152469 | Milleker et al. | Dec 2006 | B2 |
7160087 | Fathallah et al. | Jan 2007 | B2 |
7161488 | Frasch | Jan 2007 | B2 |
7162290 | Levin | Jan 2007 | B1 |
7162927 | Selvan et al. | Jan 2007 | B1 |
7169128 | Kriesel et al. | Jan 2007 | B2 |
7190275 | Goldberg et al. | Mar 2007 | B2 |
7258534 | Fathallah et al. | Aug 2007 | B2 |
7327273 | Hung et al. | Feb 2008 | B2 |
7364562 | Braig et al. | Apr 2008 | B2 |
7367942 | Grage et al. | May 2008 | B2 |
7377148 | Cassidy et al. | May 2008 | B2 |
7415895 | Kurisaki et al. | Aug 2008 | B2 |
7462161 | O'Mahony et al. | Dec 2008 | B2 |
7503903 | Carlisle et al. | Mar 2009 | B2 |
7556616 | Fathallah et al. | Jul 2009 | B2 |
7571024 | Duncan et al. | Aug 2009 | B2 |
7608042 | Golberger et al. | Oct 2009 | B2 |
7615007 | Shults et al. | Nov 2009 | B2 |
7621892 | Fago et al. | Nov 2009 | B2 |
7693697 | Westenskow et al. | Apr 2010 | B2 |
7707897 | Ong | May 2010 | B2 |
7722537 | Sterling et al. | May 2010 | B2 |
7766630 | Fathallah et al. | Aug 2010 | B2 |
7771389 | Grispo et al. | Aug 2010 | B2 |
7775126 | Eckhardt | Aug 2010 | B2 |
7775127 | Wade | Aug 2010 | B2 |
7784330 | Angelescu et al. | Aug 2010 | B2 |
7810401 | Brown et al. | Oct 2010 | B2 |
7819838 | Ziegler et al. | Oct 2010 | B2 |
7846131 | Hudson et al. | Dec 2010 | B2 |
7850659 | Trombley, III et al. | Dec 2010 | B1 |
7866201 | Tutu et al. | Jan 2011 | B1 |
7884735 | Newkirk | Feb 2011 | B2 |
7895053 | Holland et al. | Feb 2011 | B2 |
7896572 | Fathallah et al. | Mar 2011 | B2 |
7905710 | Wang et al. | Mar 2011 | B2 |
7933780 | de la Huerga | Apr 2011 | B2 |
7935077 | Thor et al. | May 2011 | B2 |
7972296 | Braig et al. | Jul 2011 | B2 |
7975491 | Smisson, III et al. | Jul 2011 | B2 |
7976508 | Hoag | Jul 2011 | B2 |
D644250 | Barber et al. | Aug 2011 | S |
7998115 | Bedingfield et al. | Aug 2011 | B2 |
8033157 | Yardimci et al. | Oct 2011 | B2 |
8048022 | Moy et al. | Nov 2011 | B2 |
8052644 | Radgowski et al. | Nov 2011 | B2 |
8057437 | Ziegler et al. | Nov 2011 | B2 |
8061219 | Rezgui et al. | Nov 2011 | B2 |
8065161 | Howard et al. | Nov 2011 | B2 |
8065924 | Ziegler et al. | Nov 2011 | B2 |
8105269 | Zhou et al. | Jan 2012 | B2 |
8147448 | Sundar et al. | Apr 2012 | B2 |
8149131 | Blomquist | Apr 2012 | B2 |
8152486 | Fathallah et al. | Apr 2012 | B2 |
8219413 | Martinez et al. | Jul 2012 | B2 |
8256984 | Fathallah et al. | Sep 2012 | B2 |
8258973 | Newkirk | Sep 2012 | B2 |
D669096 | Katsura | Oct 2012 | S |
8286977 | Butler et al. | Oct 2012 | B2 |
8313308 | Lawless et al. | Nov 2012 | B2 |
8315885 | Krogh et al. | Nov 2012 | B2 |
8317698 | Lowery | Nov 2012 | B2 |
8380536 | Howard et al. | Feb 2013 | B2 |
D677784 | Marguerie | Mar 2013 | S |
8403908 | Jacobson et al. | Mar 2013 | B2 |
D679800 | Gusky et al. | Apr 2013 | S |
8417311 | Rule | Apr 2013 | B2 |
D682318 | Goh | May 2013 | S |
8449500 | DelCastillo et al. | May 2013 | B2 |
8449524 | Braig et al. | May 2013 | B2 |
8491523 | Thor et al. | Jul 2013 | B2 |
8506552 | Rebours | Aug 2013 | B2 |
8518021 | Stewart et al. | Aug 2013 | B2 |
8523797 | Lowery et al. | Sep 2013 | B2 |
8523813 | Grispo et al. | Sep 2013 | B2 |
8581454 | Corrington et al. | Nov 2013 | B2 |
8591491 | Moy et al. | Nov 2013 | B2 |
8657778 | Ziegler et al. | Feb 2014 | B2 |
D700626 | Zhangyan et al. | Mar 2014 | S |
8666769 | Butler et al. | Mar 2014 | B2 |
D703311 | Daly | Apr 2014 | S |
8731960 | Butler et al. | May 2014 | B2 |
8768719 | Wehba et al. | Jul 2014 | B2 |
8777590 | Moy et al. | Jul 2014 | B2 |
8801656 | Lowery et al. | Aug 2014 | B2 |
8926562 | Fathallah et al. | Jan 2015 | B2 |
D728779 | Sabin et al. | May 2015 | S |
D734475 | Ross | Jul 2015 | S |
9072831 | Kelly et al. | Jul 2015 | B2 |
D736370 | Sabin et al. | Aug 2015 | S |
9174145 | Weissenbach et al. | Nov 2015 | B2 |
D752736 | Chandrasenan et al. | Mar 2016 | S |
D759230 | Gordon et al. | Jun 2016 | S |
D759804 | Singh et al. | Jun 2016 | S |
D765832 | Hochman et al. | Sep 2016 | S |
D767756 | Sabin | Sep 2016 | S |
9468713 | Hoenninger, III | Oct 2016 | B2 |
D776802 | Loew et al. | Jan 2017 | S |
9545475 | Borges et al. | Jan 2017 | B2 |
9545476 | Qi et al. | Jan 2017 | B2 |
D797275 | Evans et al. | Sep 2017 | S |
9799274 | Alberti et al. | Oct 2017 | B2 |
D804017 | Sabin | Nov 2017 | S |
D805183 | Sabin et al. | Dec 2017 | S |
9849233 | Edwards et al. | Dec 2017 | B1 |
D814021 | Sabin | Mar 2018 | S |
D815726 | Bjelovuk et al. | Apr 2018 | S |
D817479 | Sabin et al. | May 2018 | S |
D817480 | Sabin et al. | May 2018 | S |
D823456 | Lacy et al. | Jul 2018 | S |
10034975 | McLennan et al. | Jul 2018 | B2 |
10039878 | Gamelin | Aug 2018 | B2 |
D830546 | Lacy et al. | Oct 2018 | S |
D831820 | Petersen | Oct 2018 | S |
D831821 | Petersen | Oct 2018 | S |
10143795 | Chen | Dec 2018 | B2 |
D840021 | Lacy et al. | Feb 2019 | S |
10260161 | Rauenbusch et al. | Apr 2019 | B2 |
D859634 | Hochman et al. | Sep 2019 | S |
D859638 | Swanbury et al. | Sep 2019 | S |
D871568 | Pratt et al. | Dec 2019 | S |
D871572 | Lacy et al. | Dec 2019 | S |
D883472 | Hogerwerf et al. | May 2020 | S |
D890914 | Ghodsi et al. | Jul 2020 | S |
D891607 | Bjelovuk et al. | Jul 2020 | S |
D893704 | Pratt et al. | Aug 2020 | S |
D899584 | Carrubba et al. | Oct 2020 | S |
D899598 | Lucio | Oct 2020 | S |
D903093 | Seddon et al. | Nov 2020 | S |
D903094 | Ghodsi et al. | Nov 2020 | S |
D909567 | Archat et al. | Feb 2021 | S |
10918787 | Shubinsky et al. | Feb 2021 | B2 |
D916275 | Kolenda et al. | Apr 2021 | S |
D921190 | Shor et al. | Jun 2021 | S |
D939079 | Harris et al. | Dec 2021 | S |
11213619 | McLennan et al. | Jan 2022 | B2 |
D963158 | Gibson et al. | Sep 2022 | S |
D965139 | Gibson et al. | Sep 2022 | S |
D972125 | Collins | Dec 2022 | S |
D982739 | Tamir | Apr 2023 | S |
D982740 | Mulcahy | Apr 2023 | S |
11660386 | Shubinsky et al. | May 2023 | B2 |
20010007932 | Kamen et al. | Jul 2001 | A1 |
20010009610 | Augustine et al. | Jul 2001 | A1 |
20010044602 | Angersbach et al. | Nov 2001 | A1 |
20020004015 | Carlisle et al. | Jan 2002 | A1 |
20020013551 | Zaitsu et al. | Jan 2002 | A1 |
20020096608 | Cedarberg | Jul 2002 | A1 |
20020099334 | Hanson et al. | Jul 2002 | A1 |
20020120229 | Miles et al. | Aug 2002 | A1 |
20020123741 | Rake et al. | Sep 2002 | A1 |
20030065537 | Evans | Apr 2003 | A1 |
20030127850 | Bischoff et al. | Jul 2003 | A1 |
20030138349 | Robinson et al. | Jul 2003 | A1 |
20030139701 | White et al. | Jul 2003 | A1 |
20030144574 | Heilman et al. | Jul 2003 | A1 |
20030175820 | Smith et al. | Sep 2003 | A1 |
20040025597 | Ericson | Feb 2004 | A1 |
20040074795 | Fischer | Apr 2004 | A1 |
20040082918 | Evans et al. | Apr 2004 | A1 |
20040176724 | Kamen et al. | Sep 2004 | A1 |
20040225409 | Duncan et al. | Nov 2004 | A1 |
20040232219 | Fowler | Nov 2004 | A1 |
20040249308 | Forssell | Dec 2004 | A1 |
20040251406 | Figueria | Dec 2004 | A1 |
20050006538 | Turi et al. | Jan 2005 | A1 |
20050055242 | Bello et al. | Mar 2005 | A1 |
20050059926 | Sage et al. | Mar 2005 | A1 |
20050074340 | Xu et al. | Apr 2005 | A1 |
20050095152 | Dale | May 2005 | A1 |
20050165384 | Gravesen et al. | Jul 2005 | A1 |
20050168941 | Sokol et al. | Aug 2005 | A1 |
20050171512 | Flaherty | Aug 2005 | A1 |
20050177110 | Azzolini | Aug 2005 | A1 |
20050209547 | Burbank et al. | Sep 2005 | A1 |
20050209563 | Hopping et al. | Sep 2005 | A1 |
20050260090 | Stark et al. | Nov 2005 | A1 |
20050268712 | Repko et al. | Dec 2005 | A1 |
20050274194 | Skinner et al. | Dec 2005 | A1 |
20050277911 | Stewart et al. | Dec 2005 | A1 |
20060030821 | Lee et al. | Feb 2006 | A1 |
20060042633 | Bishop et al. | Mar 2006 | A1 |
20060070669 | Mabry et al. | Apr 2006 | A1 |
20060079831 | Gilbert | Apr 2006 | A1 |
20060136095 | Rob et al. | Jun 2006 | A1 |
20060142692 | Jacobson et al. | Jun 2006 | A1 |
20060173253 | Ganapathy et al. | Aug 2006 | A1 |
20060181695 | Sage, Jr. | Aug 2006 | A1 |
20060187069 | Duan | Aug 2006 | A1 |
20060189858 | Sterling et al. | Aug 2006 | A1 |
20060189925 | Gable et al. | Aug 2006 | A1 |
20060189926 | Hall et al. | Aug 2006 | A1 |
20060194325 | Gable et al. | Aug 2006 | A1 |
20060195045 | Gable et al. | Aug 2006 | A1 |
20060195058 | Gable et al. | Aug 2006 | A1 |
20060200070 | Callicoat et al. | Sep 2006 | A1 |
20060200071 | Sterling et al. | Sep 2006 | A1 |
20060200094 | Holz | Sep 2006 | A1 |
20060229531 | Goldberger et al. | Oct 2006 | A1 |
20060235348 | Callicoat et al. | Oct 2006 | A1 |
20060241550 | Kamen et al. | Oct 2006 | A1 |
20060260416 | Sage et al. | Nov 2006 | A1 |
20060266128 | Clark et al. | Nov 2006 | A1 |
20070038188 | Bialecki et al. | Feb 2007 | A1 |
20070060869 | Tolle et al. | Mar 2007 | A1 |
20070060872 | Hall et al. | Mar 2007 | A1 |
20070112297 | Plahey et al. | May 2007 | A1 |
20070129618 | Goldberger et al. | Jun 2007 | A1 |
20070151366 | McDonald et al. | Jul 2007 | A1 |
20070179436 | Braig et al. | Aug 2007 | A1 |
20070225675 | Robinson et al. | Sep 2007 | A1 |
20070239096 | Keenan et al. | Oct 2007 | A1 |
20070250339 | Mallett et al. | Oct 2007 | A1 |
20080039824 | Fathallah et al. | Feb 2008 | A1 |
20080051732 | Chen | Feb 2008 | A1 |
20080065420 | Tirinato et al. | Mar 2008 | A1 |
20080086042 | Brister et al. | Apr 2008 | A1 |
20080086044 | Brister et al. | Apr 2008 | A1 |
20080097288 | Levin et al. | Apr 2008 | A1 |
20080108942 | Brister et al. | May 2008 | A1 |
20080116157 | Fulbrook et al. | May 2008 | A1 |
20080145249 | Smisson | Jun 2008 | A1 |
20080208103 | Demers et al. | Aug 2008 | A1 |
20090004767 | Parks et al. | Jan 2009 | A1 |
20090018483 | Walker et al. | Jan 2009 | A1 |
20090046402 | Malkus et al. | Feb 2009 | A1 |
20090069743 | Krishnamoorthy et al. | Mar 2009 | A1 |
20090105646 | Hendrixson et al. | Apr 2009 | A1 |
20090143711 | Braig et al. | Jun 2009 | A1 |
20090240123 | Siebrecht et al. | Sep 2009 | A1 |
20100137778 | Kunjan et al. | Jun 2010 | A1 |
20100152681 | Mathias | Jun 2010 | A1 |
20100271218 | Hoag et al. | Oct 2010 | A1 |
20100280486 | Khair et al. | Nov 2010 | A1 |
20110005606 | Bartels et al. | Jan 2011 | A1 |
20110015610 | Plahey et al. | Jan 2011 | A1 |
20110060199 | Robinson et al. | Mar 2011 | A1 |
20110060758 | Schlotterbeck et al. | Mar 2011 | A1 |
20110106462 | Kilburn et al. | May 2011 | A1 |
20110213395 | Corrington et al. | Sep 2011 | A1 |
20110264043 | Kotnick et al. | Oct 2011 | A1 |
20110264044 | Bartz et al. | Oct 2011 | A1 |
20110313318 | Rule et al. | Dec 2011 | A1 |
20110313358 | Hariharesan et al. | Dec 2011 | A1 |
20120035418 | Talbert et al. | Feb 2012 | A1 |
20120065482 | Robinson et al. | Mar 2012 | A1 |
20120078218 | Barnes | Mar 2012 | A1 |
20120130341 | Whitley | May 2012 | A1 |
20120145616 | Weissenbach et al. | Jun 2012 | A1 |
20120245554 | Kawamura | Sep 2012 | A1 |
20120271226 | Farrell et al. | Oct 2012 | A1 |
20130079710 | Krogh et al. | Mar 2013 | A1 |
20130165900 | Braig et al. | Jun 2013 | A1 |
20130177455 | Kamen et al. | Jul 2013 | A1 |
20130253946 | Broselow | Sep 2013 | A1 |
20130274669 | Stempfle et al. | Oct 2013 | A1 |
20130281965 | Kamen et al. | Oct 2013 | A1 |
20130297330 | Kamen et al. | Nov 2013 | A1 |
20150005935 | Bae et al. | Jan 2015 | A1 |
20150133861 | McLennan et al. | May 2015 | A1 |
20150167651 | Balteanu et al. | Jun 2015 | A1 |
20160051750 | Tsoukalis | Feb 2016 | A1 |
20170132867 | Berg et al. | May 2017 | A1 |
20180300994 | Nelson et al. | Oct 2018 | A1 |
20190059859 | Pinch | Feb 2019 | A1 |
20190060539 | Siess et al. | Feb 2019 | A1 |
20190298579 | Moore et al. | Oct 2019 | A1 |
20190351131 | Butterfield et al. | Nov 2019 | A1 |
20210304864 | Kamen et al. | Sep 2021 | A1 |
20220362457 | McLennan et al. | Nov 2022 | A1 |
20230310735 | Cousineau | Oct 2023 | A1 |
Number | Date | Country |
---|---|---|
2 808 379 | Feb 2012 | CA |
304975990 | Jan 2019 | CN |
306797374 | Aug 2021 | CN |
37 42 268 | Jun 1989 | DE |
0 197 705 | Oct 1986 | EP |
0 306 130 | Mar 1989 | EP |
0 396 003 | Nov 1990 | EP |
0 423 978 | Apr 1991 | EP |
0 429 866 | Jun 1991 | EP |
0 447 985 | Sep 1991 | EP |
0 450 736 | Oct 1991 | EP |
0 483 794 | May 1992 | EP |
0 510 881 | Oct 1992 | EP |
0 569 030 | Nov 1993 | EP |
0 477 551 | Jan 1995 | EP |
0 481 656 | Aug 1995 | EP |
0 697 898 | Feb 1996 | EP |
0 839 062 | May 1998 | EP |
0 891 784 | Jan 1999 | EP |
0 960 627 | Dec 1999 | EP |
1 177 802 | Feb 2002 | EP |
2 742 961 | Jun 2014 | EP |
01-265973 | Oct 1989 | JP |
02-093917 | Jul 1990 | JP |
09-327512 | Dec 1997 | JP |
10-239193 | Sep 1998 | JP |
2002-119587 | Apr 2002 | JP |
3102285 | Mar 2004 | JP |
2007-071695 | Mar 2007 | JP |
2008-539964 | Nov 2008 | JP |
4322661 | Jun 2009 | JP |
2009-148592 | Jul 2009 | JP |
2012-010718 | Jan 2012 | JP |
D1467576 | Apr 2013 | JP |
2014-104011 | Jun 2014 | JP |
5716879 | Mar 2015 | JP |
D1711790 | Apr 2022 | JP |
D192262 | Aug 2018 | TW |
D209965 | Feb 2021 | TW |
WO 91016087 | Oct 1991 | WO |
WO 92017226 | Oct 1992 | WO |
WO 93005829 | Apr 1993 | WO |
WO 93012828 | Jul 1993 | WO |
WO 94009847 | May 1994 | WO |
WO 95024229 | Sep 1995 | WO |
WO 95031233 | Nov 1995 | WO |
WO 96035472 | Nov 1996 | WO |
WO 98013080 | Apr 1998 | WO |
WO 99010028 | Mar 1999 | WO |
WO 99010830 | Mar 1999 | WO |
WO 00057941 | Oct 2000 | WO |
WO 00066203 | Nov 2000 | WO |
WO 01039816 | Jun 2001 | WO |
WO 02027276 | Apr 2002 | WO |
WO 02036044 | May 2002 | WO |
WO 02087664 | Nov 2002 | WO |
WO 02103209 | Dec 2002 | WO |
WO 2004069095 | Aug 2004 | WO |
WO 2004070994 | Aug 2004 | WO |
WO 2005000378 | Jan 2005 | WO |
WO 2005082450 | Sep 2005 | WO |
WO 2005118015 | Dec 2005 | WO |
WO 2007008692 | Jan 2007 | WO |
WO 2007124070 | Nov 2007 | WO |
WO 2008144575 | Nov 2008 | WO |
WO 2009021705 | Feb 2009 | WO |
WO 2009039203 | Mar 2009 | WO |
WO 2009039214 | Mar 2009 | WO |
WO 2010048644 | Apr 2010 | WO |
WO 2011159956 | Dec 2011 | WO |
WO 2014131729 | Sep 2014 | WO |
WO 2017144366 | Aug 2017 | WO |
WO 2020214717 | Oct 2020 | WO |
WO 2023192791 | Oct 2023 | WO |
Entry |
---|
“CritiCore® Monitor: Critical Fluid Output and Core Bladder Temperature Monitor”, BARD Urological Catheter Systems, Advertisement, 2005, pp. 2. |
“Differential Pressure Transmitter, Series PD-39 X”, SensorsOne Ltd., Advertisement, Dec. 2005, pp. 2. |
Galt et al., “Personal Digital Assistant-Based Drug Information Sources: Potential to Improve Medication Safety”, Journal of Medical Library Association, Apr. 2005, vol. 93, No. 2, pp. 229-236. |
International Search Report and Written Opinion received in PCT Application No. PCT/IB2016/052830, dated Aug. 9, 2016 in 9 pages. |
International Preliminary Report on Patentability and Written Opinion received in PCT Application No. PCT/IB2016/052830, dated Dec. 7, 2017 in 8 pages. |
Kutschka et al., “A New Minimized Perfusion Circuit Provides Highly Effective Ultrasound Controlled Deairing”, Artificial Organs, 2007, vol. 31, No. 3, pp. 215-220. |
Merry et al., “A New, Safety-Oriented, Integrated Drug Administration and Automated Anesthesia Record System”, Anesthesia & Analgesia, Aug. 2001, vol. 93, No. 2 pp. 385-390. |
Palanchon et al., “Acoustical Bubble Trapper Applied to Hemodialysis”, Ultrasound in Medicine & Biology, Apr. 2008, vol. 34, No. 4, pp. 681-684. |
Parlex, “Medical Device Product Examples”, Johnson Medtech, Published at least as early as May 2008, pp. 2. |
Stegmayr et al., “Development of Air Micro Bubbles in the Venous Outlet Line: An In Vitro Analysis of Various Air Traps Used for Hemodialysis”, Artificial Organs, 2007, vol. 31, No. 6, pp. 483-488. |
“ICU Medical Receives FDA Clearance for Plum Duo™ Infusion Pump and LifeShield™ Infusion Safety Software”, PR Newswire, https://www.prnewswire.com/news-releases/icu-medical-receives-fda-clearance-for-plum-duo-infusion-pump-and-lifeshield-infusion-safety-software-301911857.html, Aug. 29, 2023, pp. 2. |
Number | Date | Country | |
---|---|---|---|
20230321340 A1 | Oct 2023 | US |
Number | Date | Country | |
---|---|---|---|
62166422 | May 2015 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15164277 | May 2016 | US |
Child | 17142823 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 17142823 | Jan 2021 | US |
Child | 18298624 | US |